Research ArticleLaboratory Studies
Positron-Labeled Angiotensin-Converting Enzyme (ACE) Inhibitor: Fluorine-18-Fluorocaptopril. Probing the ACE Activity In Vivo by Positron Emission Tomography
D.-R. Hwang, W.C. Eckelman, C.J. Mathias, E.W. Petrillo, J. Lloyd and M.J. Welch
Journal of Nuclear Medicine September 1991, 32 (9) 1730-1737;
D.-R. Hwang
W.C. Eckelman
C.J. Mathias
E.W. Petrillo Jr.
J. Lloyd


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Positron-Labeled Angiotensin-Converting Enzyme (ACE) Inhibitor: Fluorine-18-Fluorocaptopril. Probing the ACE Activity In Vivo by Positron Emission Tomography
D.-R. Hwang, W.C. Eckelman, C.J. Mathias, E.W. Petrillo, J. Lloyd, M.J. Welch
Journal of Nuclear Medicine Sep 1991, 32 (9) 1730-1737;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Cardiac Positron Emission Tomography/Computed Tomography Imaging of the Renin-Angiotensin System in Humans Holds Promise for Image-Guided Approach to Heart Failure Therapy
- Molecular Imaging of Human ACE-1 Expression in Transgenic Rats
- Synthesis and Evaluation of a Series of 99mTc(CO)3+ Lisinopril Complexes for In Vivo Imaging of Angiotensin-Converting Enzyme Expression
- Exposing ACE up the Sleeve...
- Evidence for Tissue Angiotensin-Converting Enzyme in Explanted Hearts of Ischemic Cardiomyopathy Using Targeted Radiotracer Technique